Antithymocyte

基本解释

Objective To observe the effect of antithymocyte globulin(ATG) on kidney transplantation rejection.
目的观察抗胸腺细胞球蛋白(ATG)预防及治疗肾移植排斥反应的效果。
Antithymocyte globulin (ATG) is employed for the treatment and prevention of acute organ rejection after transplantation.
抗胸腺细胞球蛋白（ATG）被用来治疗和预防器官移植后的急性排斥反应。
Pretreatment of patients consisted of a combination of antithymocyte globulin, cyclophosphamide, and low-dose total body irradiation.
预处理方案为联合使用环磷酰胺、抗胸腺球蛋白和小剂量全身照射。
Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
采用抗胸腺细胞球蛋白（ATG）或抗淋巴细胞球蛋白（ALG）免疫疗法是不适宜于骨髓移植患儿的主要治疗方法。
Abstract：Immunosuppression for immunologically high-risk renal transplant patients usually inoles antithymocyte globulin induction with triple drug maintenance therapy.
摘要:肾移植免疫高危患者的免疫抑制方案通常是予抗胸腺细胞球蛋白诱导免疫抑制;然后以三联免疫抑制药物维持治疗.